Clinical Management of Triple-Class Refractory Multiple Myeloma: A Review of Current Strategies and Emerging Therapies

Major progress has been made in the upfront treatment of multiple myeloma, but the disease ultimately relapses and leads to death in the vast majority of those afflicted. New treatment strategies and modalities are necessary to treat myeloma in relapse, particularly in cases of triple-refractory sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Stalker, Margaret E., Mark, Tomer M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315521/
https://www.ncbi.nlm.nih.gov/pubmed/35877215
http://dx.doi.org/10.3390/curroncol29070355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315521/
https://www.ncbi.nlm.nih.gov/pubmed/35877215
http://dx.doi.org/10.3390/curroncol29070355

Ejemplares similares